Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870"	Supported		Supported	Cytosol		NA	NA		700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	23.3	39.3	10.8	40.3	25.4	23.1	26.2	18.5	25.7	23.4	29.6	32.2	31.5	26.5	24.9	18.6	17.9	27.3	31.3	25.2	32.9	12.0	11.3	26.1	16.7	28.5	67.3	15.6	15.7	27.3	38.1	44.9	100.6	18.6	23.1	41.9	33.2	35.0	17.4	52.8	16.8	18.3	20.4	30.1	22.7	32.1	6.9	57.9	15.9	12.0	13.5	11.6	51.4	12.1	45.5	16.1	37.9	34.5	15.3	17.3	16.8	17.1	15.4	49.4	32.4	48.9	29.5	24.5	33.8	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7	8.9	17.3	8.2	15.7	7.3	35.7	22.2	17.8	14.7	11.4	8.7	17.7	53.2	29.9	24.7	8.6	14.3	9.8	46.7	25.3	24.1	12.2	18.2	20.7	43.2	23.5	52.4	22.4	19.0	9.4	5.2	29.1	9.8	11.8	34.3	13.3	35.9	23.6	8.6	38.2	27.4	38.4	0.0	13.9	17.5	29.0	7.4	43.5	10.5	12.1	13.3
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 92.3;Early spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		110000	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.4	3.8	4.9	14.8	19.3	17.8	4.4	19.1	21.8	13.2	23.9	9.3	17.9	11.6	5.6	24.1	0.0	19.2	16.2	21.7	18.2	33.8	3.7	6.5	6.5	7.1	46.3	13.5	14.4	29.3	17.1	11.4	12.7	0.0	17.4	28.8	10.9	41.0	13.0	11.3	9.5	0.0	18.5	26.5	6.8	4.6	8.2	14.5	0.0	12.5	10.6	14.1	4.7	13.4	20.9	3.8	0.0	0.0	6.0	5.4	5.1	13.5	0.2	30.5	27.8	7.4	0.0	7.1	10.7	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3	17.9	31.5	21.7	25.4	12.8	11.7	6.7	2.5	92.3	27.3	10.4	5.9	18.8	8.3	35.4	93.7	13.7	18.6	0.0	34.2	34.8	12.6	16.1	20.7	16.8	18.9	14.3	18.3	13.5	15.1	39.9	11.5	14.7	8.5	14.4	16.9	10.8	37.5	21.0	18.0	13.4	10.0	6.5	14.1	39.5	24.2	10.5	27.0	24.2	14.3	35.5
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.9	19.7	16.8	17.8	18.8	23.6	38.6	24.0	26.9	26.3	25.8	42.5	20.9	56.0	37.6	19.7	19.2	27.7	25.8	31.0	47.8	25.6	23.1	34.1	19.5	44.1	24.3	45.5	22.7	22.7	25.1	29.3	26.5	33.6	14.5	26.3	36.5	17.9	21.8	22.5	34.9	39.2	19.8	19.5	18.8	42.6	36.6	39.1	31.6	18.7	12.0	22.8	18.4	16.7	18.7	18.0	18.3	32.5	10.8	23.0	23.0	16.9	23.8	49.3	26.8	60.2	36.2	34.7	14.2	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0	56.6	49.0	70.0	90.1	67.0	59.0	74.7	38.2	48.2	51.2	43.6	31.4	98.6	77.9	93.1	1.7	54.2	20.6	23.3	71.9	123.6	68.6	66.4	31.2	58.6	82.4	50.9	37.0	53.4	79.2	4.0	64.2	52.3	59.1	111.0	39.3	83.6	78.4	23.0	72.2	75.2	23.7	51.8	71.3	25.1	45.4	63.2	114.1	63.3	53.4	76.3
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	38.0	29.6	32.9	34.9	39.5	27.7	25.7	28.9	22.7	24.4	57.9	22.0	41.6	10.4	32.3	34.9	31.8	34.6	28.3	22.2	31.5	25.9	19.4	32.4	52.2	27.0	23.7	40.9	32.8	41.1	21.5	28.1	28.0	54.1	45.7	25.1	14.9	22.4	12.7	26.9	35.7	39.8	23.8	24.6	56.6	23.5	13.3	33.1	26.0	23.1	38.3	40.3	20.8	35.4	57.1	24.9	12.3	22.7	37.6	36.7	31.0	35.2	49.0	28.3	37.6	38.8	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8	65.5	52.5	37.9	33.6	17.6	45.2	67.4	15.3	69.6	69.4	29.6	62.8	36.3	18.3	58.3	19.1	33.8	24.4	23.3	87.1	48.7	27.0	24.9	47.4	18.8	38.0	39.7	29.4	22.1	23.8	7.4	43.7	27.7	20.3	53.3	32.2	45.5	61.8	14.4	44.6	21.4	47.0	38.8	27.8	57.6	34.9	17.8	30.6	29.8	41.8	29.3
FARSA	"CML33, FARSL, FARSLA"	ENSG00000179115	"Phenylalanyl-tRNA synthetase alpha subunit"	Q9Y285	19	12922479-12934037	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001911	Enhanced		Approved	Cytosol		NA	NA		11000	Cytosol		"HPA001911: AB_1848427"	"unprognostic (1.52e-1)"	"prognostic favorable (8.23e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.22e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.45e-3)"	"prognostic favorable (8.32e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.84e-2)"	18.0	20.7	24.8	23.6	29.5	23.5	15.4	24.6	49.2	17.7	24.0	18.3	14.9	22.1	16.1	13.1	26.6	21.2	16.3	24.9	23.9	30.1	23.0	39.6	13.4	27.6	25.6	28.1	19.1	26.7	17.8	21.0	22.9	29.1	18.5	15.0	14.8	25.1	20.4	33.3	27.8	18.8	15.3	17.2	21.2	18.9	17.1	18.6	32.7	24.4	15.2	22.0	19.5	15.2	34.7	42.2	28.9	41.2	38.3	40.2	39.7	29.1	27.6	11.1	23.9	7.7	7.3	20.0	21.0	13.6	30.1	23.7	33.8	12.4	32.3	33.8	11.8	12.2	22.4	27.0	24.0	11.0	18.9	40.7	25.3	24.3	26.7	25.0	48.8	33.4	10.0	17.7	23.2	18.7	9.9	16.3	32.9	38.2	6.8	12.6	39.2	57.9	60.7	34.6	18.1	46.9	30.0	11.5	41.4	15.8	17.2	34.8	31.9	14.1	24.4	14.9	5.4	19.2	29.7	15.6	24.5	10.8	37.2	39.0	45.2	38.5	33.6	22.2	44.1	25.3	17.3	39.2	28.9	32.5	41.2	40.2	31.9	32.0	30.2	42.2	34.7	32.9	31.2	2.5	38.3	30.4	34.1	29.4	39.7	24.8	29.5	24.6	49.2	23.9	30.1	25.6	28.1	29.1	18.6	8.9	21.3	25.9	20.3	22.6	23.5	22.1	2.5	13.4	13.6	22.7	9.8	74.5	49.7	50.2	3.9	18.0	20.6	23.3	40.4	65.4	18.4	19.3	23.1	22.9	56.1	17.5	21.9	17.2	26.9	7.5	17.5	19.2	32.1	52.3	22.0	19.4	40.6	24.6	12.4	43.4	13.0	6.5	20.6	14.6	41.5	25.7	80.9	27.7	31.6	19.5
FARSB	"FARSLB, FRSB, PheHB"	ENSG00000116120	"Phenylalanyl-tRNA synthetase beta subunit"	Q9NSD9	2	222570536-222656337	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036677, HPA036678, HPA061398"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504"	"unprognostic (9.95e-3)"	"unprognostic (1.86e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.45e-10)"	"unprognostic (8.89e-3)"	"unprognostic (4.51e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.25e-4)"	15.7	10.8	11.9	12.6	23.5	11.5	16.0	15.1	28.5	11.6	17.3	13.7	5.9	15.9	14.2	11.7	19.1	10.8	7.2	13.4	13.7	15.1	11.7	18.3	9.0	12.0	11.6	18.0	16.7	18.6	15.0	15.7	8.8	29.4	11.2	20.7	9.6	12.3	11.5	33.2	14.1	11.5	14.9	9.7	10.3	13.9	15.6	11.2	15.6	11.9	17.1	14.2	11.8	12.0	16.3	16.0	1.2	11.4	18.5	20.0	14.6	22.2	13.1	15.3	20.0	14.0	20.1	23.6	22.7	14.4	22.5	18.4	33.2	12.3	10.9	17.3	16.6	18.7	18.8	29.4	25.5	33.1	16.3	15.2	25.1	14.8	21.1	21.8	36.5	10.4	13.4	20.0	25.6	39.4	8.0	21.2	19.3	37.7	22.6	27.3	20.8	21.8	20.7	19.5	26.9	16.4	21.5	36.8	35.4	18.4	14.6	24.8	8.1	9.5	16.7	19.6	19.5	15.5	15.4	11.5	19.3	15.9	27.6	27.4	10.8	10.8	39.9	15.0	24.6	20.1	0.2	8.5	1.2	11.4	10.3	16.8	16.3	15.4	14.0	16.0	14.0	20.0	17.2	0.9	18.5	11.4	8.0	13.3	14.6	11.9	23.5	15.1	28.5	13.7	15.1	11.6	18.0	29.4	11.2	6.0	5.4	20.0	16.1	11.0	15.1	26.0	2.5	16.0	10.3	21.0	3.9	30.6	29.9	19.9	43.7	9.9	12.3	0.0	26.1	35.9	12.8	11.4	4.7	16.2	24.6	3.2	20.1	7.4	9.7	57.3	14.1	10.8	6.8	9.0	19.0	9.8	18.6	7.0	18.7	20.7	17.1	6.5	16.5	59.3	37.3	12.4	18.5	13.3	40.3	12.0
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavorable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.5	16.6	14.8	52.3	27.6	41.5	28.0	50.2	45.5	25.9	52.5	22.1	16.8	56.5	15.2	61.1	40.7	26.6	36.8	31.9	45.6	13.5	17.2	26.1	13.6	18.6	87.7	38.4	23.1	39.5	56.0	37.1	44.1	18.4	33.2	52.5	51.7	65.9	41.1	20.7	33.4	26.6	39.8	31.0	31.8	16.9	13.0	43.9	29.7	15.2	17.8	29.9	13.4	37.6	71.4	27.6	33.5	58.9	30.4	12.3	41.3	24.7	31.7	65.2	54.6	66.5	43.0	58.2	57.8	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9	38.7	27.4	35.6	34.3	29.9	23.3	30.7	25.5	14.7	27.3	19.2	21.6	41.1	28.2	79.9	48.1	24.6	13.9	0.0	131.2	61.8	33.2	32.2	40.3	27.0	39.9	17.5	25.2	31.9	25.5	44.0	21.6	32.4	32.1	57.7	36.9	20.2	111.3	7.0	21.5	31.8	15.7	12.9	30.0	71.9	80.1	24.1	33.3	25.4	22.3	44.7
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.6	30.2	18.2	39.7	23.2	25.3	19.2	33.3	24.0	38.5	36.0	54.9	17.5	27.5	29.3	37.3	31.1	21.7	27.6	53.5	36.3	23.3	34.1	19.8	39.2	34.8	28.8	31.1	17.0	26.7	16.8	41.9	23.9	23.0	38.6	17.1	17.3	22.9	40.0	35.5	22.1	29.0	14.3	16.7	19.9	20.5	26.4	22.4	30.9	26.4	28.6	27.7	27.6	40.2	26.2	18.3	29.6	17.5	32.2	36.1	13.9	20.3	44.8	23.1	27.4	27.8	27.4	26.1	24.7	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5	14.9	19.4	29.8	29.5	27.2	27.3	7.7	20.4	14.7	15.9	26.2	13.7	35.0	38.1	46.0	30.2	30.6	23.2	0.0	37.0	41.1	27.2	20.1	15.1	76.4	31.4	28.6	24.8	26.4	17.5	15.9	23.3	22.3	35.4	61.3	22.2	20.7	37.7	23.0	32.5	33.8	20.0	45.3	41.8	29.6	30.4	28.4	30.1	30.2	25.5	25.7
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.0	36.3	20.3	32.0	33.5	37.8	32.2	37.2	35.5	29.5	36.1	12.7	22.6	47.6	14.7	57.4	32.5	43.9	62.6	48.4	37.3	29.9	23.3	29.0	31.3	22.6	70.8	39.5	21.5	36.8	54.4	51.4	85.1	19.4	31.0	57.2	51.1	43.3	41.4	25.5	36.5	15.4	32.9	74.5	33.6	25.6	30.9	22.9	24.3	17.6	26.0	21.6	25.2	27.7	35.0	22.9	22.2	24.8	22.8	21.8	27.3	36.0	30.2	31.7	40.5	25.2	51.0	30.5	40.2	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9	17.9	25.5	29.7	27.4	60.8	34.2	44.5	40.8	24.1	27.3	17.4	43.2	23.5	13.3	22.2	8.9	20.8	5.4	0.0	25.9	26.2	31.1	25.2	36.9	26.0	15.7	9.5	11.5	16.0	21.6	4.0	26.4	17.7	13.5	11.8	23.8	15.5	26.0	8.6	27.6	29.1	34.6	6.5	32.5	39.2	38.1	59.2	14.5	18.7	26.3	27.4
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	27.2	31.9	23.3	32.0	25.0	25.3	45.9	23.1	28.4	50.9	38.4	56.3	35.9	49.2	25.6	30.7	24.3	39.3	46.9	42.2	55.7	14.3	24.1	27.0	27.9	58.2	45.9	40.6	30.5	29.7	30.4	45.0	73.3	26.0	41.4	43.5	45.0	11.8	38.4	63.0	41.7	43.5	49.3	40.1	23.5	55.0	20.9	60.0	40.8	23.2	35.1	28.5	58.1	21.2	25.8	26.6	28.7	38.5	22.8	28.2	29.1	21.5	33.0	25.4	29.0	117.4	24.6	34.8	34.3	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5	41.7	22.7	66.3	80.5	40.9	19.6	83.2	53.5	42.8	59.1	38.4	33.4	104.3	89.5	100.0	165.6	61.2	50.2	46.7	126.0	122.6	54.5	53.6	38.2	37.5	80.9	11.1	54.8	39.3	59.8	236.5	43.4	52.9	33.7	143.3	61.7	20.0	101.6	42.1	47.7	58.7	38.2	45.3	49.9	89.9	114.1	39.5	92.0	63.4	85.8	94.5
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA		14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: AB_2677185"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.5	24.3	28.2	46.2	23.4	30.5	43.9	24.1	17.8	24.4	35.3	25.4	22.5	31.3	14.9	31.6	30.9	17.6	47.6	39.6	42.7	26.9	28.0	35.7	30.8	14.7	32.4	50.7	23.7	23.9	39.9	39.9	69.3	22.0	33.2	46.5	39.7	58.7	26.1	17.0	39.1	31.1	43.7	16.6	27.0	30.3	35.5	31.2	18.6	18.6	27.8	35.1	26.2	28.9	60.8	28.0	32.8	43.8	32.5	28.5	19.0	25.8	36.0	30.5	45.0	51.2	31.0	53.6	33.2	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5	26.8	57.1	43.4	48.5	24.6	46.8	120.8	22.9	81.7	77.3	45.4	39.3	32.4	43.1	59.7	27.5	55.0	26.5	0.0	47.0	33.7	27.8	49.5	77.6	28.0	32.9	20.6	30.6	29.4	40.0	22.8	58.1	39.7	21.9	59.5	33.8	40.2	49.7	28.1	56.6	52.5	48.0	32.3	59.7	106.6	46.2	31.0	27.6	32.0	43.8	38.2
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.8	23.4	15.7	27.1	17.6	10.7	28.9	24.1	28.2	25.5	27.3	25.1	18.7	29.6	16.0	29.2	15.9	19.2	35.7	31.1	26.8	25.6	15.5	20.9	8.7	14.1	39.2	31.4	24.0	15.5	48.4	29.2	75.7	12.2	18.2	37.8	32.3	63.4	17.7	23.3	28.1	23.7	29.6	27.0	25.8	24.4	118.3	30.6	19.2	13.2	20.9	21.3	12.5	19.3	33.4	18.4	25.4	41.2	13.5	9.2	27.3	13.3	14.3	58.2	58.8	35.7	22.7	23.9	31.5	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9	35.7	22.7	29.8	15.6	16.6	14.8	10.1	12.7	28.1	29.6	17.4	31.4	24.6	5.0	32.2	19.0	13.7	11.1	0.0	39.9	18.6	15.5	18.1	26.7	11.3	17.0	6.4	14.5	8.0	12.0	6.6	12.0	22.6	3.3	32.5	10.3	11.5	33.5	14.0	14.2	9.8	28.8	12.9	17.9	33.4	34.1	14.1	31.8	20.3	9.7	23.1
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.5	3.5	3.4	6.0	4.9	3.4	3.0	2.4	4.2	3.1	3.0	2.2	3.0	9.0	3.2	4.3	5.1	7.6	6.4	4.2	3.0	3.4	4.7	3.8	3.4	2.5	5.7	5.2	1.2	4.9	5.3	1.7	3.7	4.4	2.8	8.0	4.0	4.3	4.7	3.5	4.1	5.5	4.7	7.3	6.1	3.8	5.0	4.1	5.1	3.0	3.5	3.6	5.7	5.3	4.3	4.7	3.3	3.7	5.2	3.7	3.8	4.3	4.7	3.7	5.3	3.5	3.3	8.4	3.8	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2	3.0	8.9	11.5	12.6	3.0	0.0	15.0	7.6	5.3	9.1	3.5	0.0	9.0	21.6	10.4	1.6	6.5	11.9	0.0	8.5	10.3	10.0	11.7	8.1	9.5	14.2	0.0	7.5	10.4	10.8	1.4	14.4	11.1	8.5	2.8	9.0	0.0	9.2	16.4	14.5	15.3	0.0	0.0	10.3	10.9	21.6	4.0	7.4	9.6	15.3	13.2
NARS	NARS1	ENSG00000134440	"Asparaginyl-tRNA synthetase"	O43776	18	57600656-57622213	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB034257: AB_2151043, HPA040017: AB_2676801"	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	30.9	36.9	35.0	28.8	42.6	19.5	31.6	47.1	51.4	28.1	49.7	24.8	31.1	42.5	30.8	31.6	40.2	27.4	26.8	40.6	40.5	36.5	66.0	41.9	26.0	23.0	39.5	39.2	29.4	29.4	52.0	35.7	25.6	49.5	33.1	46.1	18.5	33.7	30.9	76.6	26.9	35.2	29.9	40.6	25.7	36.0	14.9	36.3	25.0	44.5	31.9	29.2	34.6	35.3	20.0	26.6	15.6	40.8	15.8	23.4	23.7	36.6	24.2	22.8	33.3	29.3	22.5	35.6	51.3	26.8	30.3	37.5	17.4	17.2	46.2	24.6	35.5	30.5	41.8	35.8	31.7	44.4	22.4	12.4	35.3	18.6	27.4	49.6	73.2	36.5	23.9	55.5	41.5	39.7	23.8	25.1	28.4	43.3	34.5	34.0	13.6	28.3	17.8	33.5	23.3	19.5	22.5	26.9	39.0	56.6	41.3	25.1	27.5	24.9	32.1	53.8	25.1	17.9	40.7	27.4	33.8	22.6	14.2	37.9	77.5	95.9	44.9	31.1	48.1	39.3	15.6	40.8	14.2	16.4	35.1	20.2	20.0	17.3	17.4	26.6	18.8	23.4	21.2	12.7	15.8	26.6	25.1	17.2	23.7	35.0	42.6	47.1	51.4	40.5	36.5	39.5	39.2	49.5	36.3	71.5	60.9	52.8	56.5	68.6	83.3	195.9	79.0	170.0	72.8	66.3	33.4	91.5	286.8	103.2	11.5	56.6	105.3	93.5	78.8	68.1	57.5	71.7	91.6	94.8	102.8	90.6	60.9	38.1	67.5	12.5	65.3	70.5	74.2	75.7	75.6	85.4	101.4	49.1	73.2	181.5	68.2	71.1	59.4	41.1	41.9	66.1	132.6	49.0	92.8	67.0
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 438.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.8	19.2	32.1	45.9	41.3	44.9	33.1	21.0	48.1	41.7	41.0	24.3	24.5	58.4	13.5	34.8	23.4	24.0	45.5	34.6	30.0	16.6	36.3	46.0	30.8	42.3	21.8	37.4	28.4	47.3	30.3	32.1	27.3	44.8	45.5	34.2	20.5	26.0	30.5	10.1	26.9	33.6	27.5	38.6	30.0	17.8	27.0	43.0	28.0	28.1	11.8	32.8	18.6	47.3	28.9	33.0	39.2	43.7	26.2	19.0	27.0	31.3	23.4	22.4	38.1	32.8	19.5	33.7	12.0	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3	20.8	57.3	55.9	52.1	59.8	10.1	50.4	40.8	22.7	35.2	38.4	9.8	160.6	58.0	67.5	150.2	50.3	110.2	23.3	94.9	127.6	48.0	47.5	38.1	41.8	85.6	19.1	62.3	50.3	98.5	438.0	54.4	55.2	45.5	120.0	127.2	20.6	67.1	71.9	34.3	63.0	13.0	45.3	43.4	18.4	46.6	75.3	156.4	69.2	176.8	57.2
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.2	32.4	24.0	26.6	33.2	38.1	41.3	40.2	34.6	41.9	49.0	55.0	29.8	29.0	33.0	38.2	43.1	26.5	31.4	54.1	54.7	30.1	21.6	19.5	29.5	34.5	28.8	46.0	20.8	29.2	28.9	45.6	21.9	25.8	33.5	15.9	29.1	14.7	44.8	25.2	19.1	18.3	39.4	24.0	22.1	8.4	35.0	27.6	37.3	31.1	22.9	28.2	30.7	35.5	41.5	30.5	32.3	19.3	33.2	30.4	27.9	23.4	46.8	14.7	26.9	29.8	33.1	32.9	28.8	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8	53.6	32.3	25.1	37.6	26.3	25.0	43.6	35.7	46.8	39.8	24.4	25.5	88.8	14.9	80.1	16.6	27.5	40.6	23.3	83.1	79.2	34.8	24.5	26.6	31.4	51.1	12.7	12.6	33.2	24.6	11.6	23.0	35.0	27.0	72.1	36.7	22.7	61.2	38.7	23.0	36.0	22.7	19.4	28.9	27.7	42.2	31.1	70.5	20.1	44.8	35.2
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol		NA	NA		100000	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	33.3	13.1	25.2	37.9	37.9	34.4	43.4	35.1	36.4	30.5	38.1	25.3	10.3	36.0	18.2	49.4	17.0	18.3	39.2	49.6	35.5	25.4	23.9	13.9	16.2	18.3	76.2	17.5	15.7	42.3	86.8	35.9	78.3	26.0	36.3	45.5	31.8	45.1	29.6	31.9	19.4	8.9	10.5	20.0	31.0	16.1	32.2	16.1	23.2	17.7	35.0	18.6	16.8	27.1	95.1	20.0	15.3	20.9	28.6	18.2	22.9	25.8	24.5	34.4	13.9	29.5	57.4	19.3	61.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0	47.6	92.0	61.1	90.9	109.9	51.2	87.9	81.5	66.9	81.9	68.0	21.6	157.2	112.7	120.1	15.1	64.7	75.8	70.0	195.0	122.6	80.4	56.7	96.0	112.9	78.0	55.6	66.7	63.8	59.4	21.0	73.1	68.8	60.8	110.0	61.3	56.1	142.9	49.1	65.4	85.4	34.4	129.4	118.7	46.1	22.4	95.2	157.6	64.0	84.6	77.6
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavorable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavorable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.7	24.9	20.9	29.5	13.8	26.2	30.4	33.5	28.4	25.3	28.7	30.4	18.6	11.8	12.2	27.6	41.7	21.3	44.5	33.1	52.3	17.5	16.2	17.2	64.0	17.3	43.0	27.6	18.4	25.0	53.2	34.9	45.2	15.8	27.1	29.6	33.7	31.9	32.4	16.5	21.5	9.5	22.2	27.1	18.5	18.3	37.1	17.4	28.8	23.8	12.3	13.9	31.0	22.7	22.1	19.3	11.9	24.7	14.3	19.9	29.7	15.7	23.5	18.8	37.0	18.5	22.2	36.4	21.6	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4	23.8	23.7	38.9	37.6	25.4	23.3	57.6	35.7	26.8	39.8	17.4	17.7	32.0	41.4	75.9	12.6	24.1	36.2	93.5	83.0	34.9	31.7	29.7	61.2	66.0	28.4	42.9	39.5	25.8	26.4	6.0	17.8	26.3	10.1	83.8	30.4	67.9	95.7	33.7	22.6	30.4	36.0	12.9	31.5	24.1	22.1	17.2	43.6	22.4	28.9	37.7
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 205.7;Late spermatids: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.2;U-266/84: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		23000	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.2	6.4	3.6	2.8	8.7	8.8	2.7	6.6	4.0	2.6	1.4	7.7	10.9	5.5	5.0	2.4	10.2	6.7	4.0	5.6	14.4	3.8	5.1	6.1	4.7	15.3	12.6	4.2	2.4	2.6	6.1	1.9	3.3	3.5	10.6	10.5	4.2	3.5	6.9	0.7	6.1	3.2	4.3	9.0	1.7	25.2	5.1	2.9	3.9	1.5	0.7	8.6	3.7	2.2	5.2	6.1	1.1	4.6	4.2	6.1	14.5	15.0	25.9	6.3	3.3	3.1	5.1	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5	6.0	8.2	11.1	8.3	7.3	7.0	7.8	7.6	8.1	9.1	15.7	5.9	19.8	8.3	30.5	205.7	9.2	18.8	23.3	36.1	40.7	10.4	7.3	9.2	21.9	26.7	1.6	22.5	6.2	9.2	188.8	19.2	12.0	6.8	10.0	12.5	7.2	28.7	5.8	12.7	11.4	12.4	19.4	8.1	24.4	29.8	11.3	13.8	6.9	19.2	7.0
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 118.8;SK-MEL-30: 143.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		53000000	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	11.1	10.6	7.0	40.7	10.1	14.4	11.2	14.4	27.9	31.0	39.2	6.9	10.0	12.1	13.5	34.3	7.6	19.0	20.2	16.4	20.0	19.2	5.8	7.8	8.1	8.5	118.8	22.2	12.8	16.3	23.6	18.0	37.5	9.4	27.8	8.2	24.4	32.1	13.2	21.3	7.6	10.4	7.0	11.4	19.3	6.4	11.0	7.7	15.1	9.8	18.7	10.9	8.6	7.5	143.4	9.4	19.1	28.2	18.4	3.3	7.5	33.9	7.5	62.6	31.8	22.5	37.4	17.3	30.2	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4	23.8	39.7	41.6	6.7	12.9	9.0	12.1	7.6	30.8	29.6	21.0	19.6	14.6	13.3	29.0	112.5	76.4	8.5	0.0	56.4	9.8	20.5	12.1	29.0	14.9	40.6	7.9	14.3	87.8	44.2	82.6	10.6	72.8	8.5	71.3	14.1	9.3	34.3	7.2	12.7	15.3	15.8	19.4	21.7	69.3	20.9	10.7	13.8	10.2	10.1	11.4
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.8	15.1	15.9	38.3	19.8	22.8	17.0	29.8	24.7	24.5	31.3	17.9	19.9	52.5	11.8	30.9	20.0	17.0	48.4	35.1	38.8	22.1	19.2	48.1	22.9	16.8	65.2	37.9	29.1	22.6	43.7	38.7	98.6	17.7	24.8	42.5	52.9	55.6	21.0	14.9	42.5	20.8	29.0	29.5	20.9	37.2	15.2	44.1	17.6	14.5	30.7	18.9	16.2	19.1	55.0	19.0	19.1	41.3	20.1	14.9	26.6	30.2	24.6	44.9	47.9	49.1	37.3	52.9	40.9	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0	20.8	45.6	14.5	22.1	22.2	19.3	14.9	5.1	34.8	34.2	8.7	25.5	36.7	3.3	30.4	14.4	19.0	12.8	0.0	71.3	38.8	20.0	22.9	12.8	23.3	35.7	30.2	16.7	7.4	22.2	12.4	11.8	21.1	13.5	35.1	12.7	10.8	50.1	3.5	10.6	9.8	19.8	12.9	24.5	26.7	19.4	21.3	31.5	33.0	17.5	30.1
